J Infect 2007,55(2):111–118 PubMedCrossRef 7 Bentley SD, Aanense

J Infect 2007,55(2):111–118.PubMedCrossRef 7. Bentley SD, Aanensen DM, Mavroidi A, Saunders D, Rabbinowitsch E, Collins M, Danohoe K, Harris D, Murphy L, Reeves

PR, et al.: Genetic analysis of the capsular biosynthetic locus from all 90 pneumococcal serotypes. PLoS Genet 2006, 2:e31.PubMedCrossRef 8. Park IH, Pritchard DG, Cartee R, Brandao A, Brandileone MC, Nahm MH: Discovery of a new capsular serotype (6C) within serogroup 6 of Streptococcus pneumoniae . J Clin Microbiol 2007,45(4):1225–1233.PubMedCrossRef 9. Jin P, Kong F, Xiao M, Oftadeh S, Zhou F, Liu C, Russell F, Gilbert GL: First report of putative Streptococcus pneumoniae serotype 6D among nasopharyngeal isolates from Fijian children. J Infect Dis 2009,200(9):1375–1380.PubMedCrossRef 10. Calix JJ, Nahm MH: A new pneumococcal serotype, 11E, has a variably inactivated wcjE gene. selleck kinase inhibitor J Infect Dis 2010,202(1):29–38.PubMedCrossRef 11. Huang SS, Platt R, Rifas-Shiman SL, Pelton SI, Goldmann D, Finkelstein JA: Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004. Pediatrics 2005,116(3):e408–413.PubMedCrossRef 12. Whitney CG, Farley MM, Hadler J, Harrison selleck products LH, Bennett NM, Lynfield R, Reingold A, Cieslak PR, Pilishvili T, Jackson D, et al.: Decline in invasive pneumococcal Trichostatin A chemical structure disease after the introduction

of protein-polysaccharide conjugate vaccine. N Engl J Med 2003,348(18):1737–1746.PubMedCrossRef 13. Hicks LA, Harrison LH, Flannery B, Hadler

JL, Schaffner W, Craig AS, Jackson D, Thomas A, Beall B, Lynfield R, et al.: Incidence of pneumococcal disease Cyclin-dependent kinase 3 due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998–2004. J Infect Dis 2007,196(9):1346–1354.PubMedCrossRef 14. Pai R, Moore MR, Pilishvili T, Gertz RE, Whitney CG, Beall B: Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States. J Infect Dis 2005,192(11):1988–1995.PubMedCrossRef 15. Gertz RE Jr, Li Z, Pimenta FC, Jackson D, Juni BA, Lynfield R, Jorgensen JH, Carvalho Mda G, Beall BW: Increased penicillin nonsusceptibility of nonvaccine-serotype invasive pneumococci other than serotypes 19A and 6A in post-7-valent conjugate vaccine era. J Infect Dis 2010,201(5):770–775.PubMed 16. Kellner JD, Scheifele D, Vanderkooi OG, Macdonald J, Church DL, Tyrrell GJ: Effects of routine infant vaccination with the 7-valent pneumococcal conjugate vaccine on nasopharyngeal colonization with Streptococcus pneumoniae in children in Calgary, Canada. Pediatr Infect Dis J 2008,27(6):526–532.PubMedCrossRef 17. Huang SS, Hinrichsen VL, Stevenson AE, Rifas-Shiman SL, Kleinman K, Pelton SI, Lipsitch M, Hanage WP, Lee GM, Finkelstein JA: Continued impact of pneumococcal conjugate vaccine on carriage in young children. Pediatrics 2009,124(1):e1–11.PubMedCrossRef 18.

Comments are closed.